NCT00617188 2017-12-28Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial CancerMasonic Cancer Center, University of MinnesotaPhase 2 Completed26 enrolled 11 charts
NCT00334295 2012-07-31Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.AstraZenecaPhase 2 Completed35 enrolled 9 charts